NCT03117439View on ClinicalTrials.gov

Beta-Glucan Driven vs. Empirical Antifungal Therapy in Critically Ill Patients

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

June 30, 2018

Study Completion Date

August 31, 2018

Conditions
Antifungal Agents
Interventions
OTHER

duration of antifungal therapy

Patients in the study group will stop antifungals in presence of a negative result of Beta Glucan Test

Trial Locations (1)

00168

Gennaro De Pascale, Rome

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

NCT03117439 - Beta-Glucan Driven vs. Empirical Antifungal Therapy in Critically Ill Patients | Biotech Hunter | Biotech Hunter